LIMIT: Neutral Versus Liberal fLuId In Traumatic Brain Injury: a Randomised Controlled Trial

Sponsor
Universita degli Studi di Genova (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05983549
Collaborator
(none)
80
2
24

Study Details

Study Description

Brief Summary

Feasibility and safety of targeting neutral vs liberal fluid balance in traumatic brain injured patients: a phase II randomized controlled trial

Condition or Disease Intervention/Treatment Phase
  • Procedure: fluid balance
N/A

Detailed Description

To determine whether a zero fluid balance strategy during the first week compared to a more liberal fluid policy (allowing positive balance) is feasible in adult intensive care unit (ICU) patients with traumatic brain injury (TBI).Participants randomized to neutral fluid balance will be assessed daily with the aim to maintain a mean daily fluid balance of 0 over the course of the first 5 days from randomization (maximum at day 7 of ICU stay). In case of need for augmentation of cerebral perfusion pressure with 0 balance, fluids will be allowed according to a predefined protocol (see further).Participants randomized to the control group will receive the standard fluid management required as determined by the treating team. Fluid strategy as randomised should be applied for at least 5 days from randomization.

Primary aim: ● Feasibility: ability to achieve a daily neutral balance (0 +/- 500 ml) in the intervention group.

Secondary aims:● Incidence of renal complications, including acute kidney injury, need for renal replacement, multiorgan failure

  • Respiratory complications including reduced partial pressure of oxygen/ fraction of inspired oxygen (P/F) ratio

  • Cardiopulmonary complications, i.e myocardial infarction, cardiac failure, cardiac arrhythmias, ventricular or supraventricular, pulmonary oedema, ventilator associated pneumonia, acute respiratory distress syndrome

  • Difference in mean and daily CPP among the groups

  • Difference in daily fluid balance and fluid input during the first 7 days after ICU admission

  • Total and daily dose of vasopressors and diuretics during ICU stay

  • Vasopressor-free days up to 28 days from ICU admission

  • ICU-free days up to 28 days

  • Ventilator-free days up to 28 days from intubation.

  • Maximum Therapy intensity level (TIL) during the 5 days of randomization

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
Participant will be blinded in knowing the arm, outcome assessors will be not involved in the study
Primary Purpose:
Treatment
Official Title:
The Effect of Neutral Versus Liberal fLuId Balance In TraumaTic Brain Injury: a Randomised Phase II Feasibility Controlled Trial
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
May 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard of care group

Patients will receive fluids according to clinical practice

Active Comparator: Neutral balance

Patients will receive fluids aiming to a neutral balance

Procedure: fluid balance
patients will receive fluids with the aim to achieve a neutral balance

Outcome Measures

Primary Outcome Measures

  1. Feasibility- rate of patients able to achieve neutral fluid balance( 0 +/- 500 ml) during the first week from ICU admission [7 days]

    Ability to target and achieve a daily and total neutral fluid balance (0 +/- 500 ml) in the intervention group. In particular,testing the hypothesis of whether all pairwise differences between group means are the same in a design of repeated measures with 7 days points. We hypothesise a mean of 0 ml in the conservative group, a mean of 1000 ml in the liberal group and standard deviation in the population of 850 ml (500 ml in the conservative group and 1000 ml in the liberal group)

Secondary Outcome Measures

  1. Safety to achieve neutral balance, i.e. the estimation of the difference of incidence of renal, pulmonary, cardiac complications between the two arms [From date of randomization until the date of intensive care unit discharge or death assessed up to 6 months]

    Complications occurring during the ICU stay

  2. Rates of patients who die and experience poor neurological outcome after 6 months from ICU admission [6 months from ICU admission and enrolment]

    at 6 months, at hospital and ICU discharge

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patients with TBI (isolated or with extracranial injuries, with and without ICP monitoring)

  • Admitted to intensive care unit

  • Age >18 years

  • Enrolment <48h after ICU admission

Exclusion Criteria:
  • Enrolled in another clinical trial that is unapproved for co-enrolment

  • Pregnant or suspected pregnancy

  • Concomitant hemorrhagic shock expected to require surgical treatment in the following 24h from inclusion or requiring polytransfusions (> 6 blood products or massive transfusion protocol)

  • Hemodynamic instability (HR > 120 despite fluid resuscitation of at least 1 liter, and systolic blood pressure < 90 mmHg) at the ICU admission requiring high dosage of norepinephrine (> 0.5 mcg/kg/min) or inotropes (any dose)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universita degli Studi di Genova

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chiara Robba, Researcher, Universita degli Studi di Genova
ClinicalTrials.gov Identifier:
NCT05983549
Other Study ID Numbers:
  • 001
First Posted:
Aug 9, 2023
Last Update Posted:
Aug 9, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2023